香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容而產生或 因倚賴該等內容而引致的任何損失承擔任何責任。 RICI HEALTHCARE HOLDINGS LIMITED （於開曼群島註冊成立的有限公司） （股份代號：1526） 補充公告 須予披露交易 收購該物業 進行收購事項的理由及裨益 董事認為，鑒於該物業所在地區徐匯區的物業市場情況以及上海及中國物業 市場的整體狀況，上海市商品房預售合同的條款（包括代價）屬公平合理。 於評估代價時，本公司已參考近期過去12個月內同類二手物業的市場單位價格 （介乎每平方米約人民幣200,000元至人民幣300,000元），以及賣方於同期及先 前階段在毗鄰地區發展的其他預售一手物業的近期成交價（自2025年9月起至該 公告日期止），其與代價具有可比性，且與代價一致。上述物業的建造工程已 告完成。本公司認為，代價與當前市價相若。在評估代價時，本公司亦已考慮 該物業本身的性質及質量。該物業為位處上海市中心徐匯區黃金地段的獨特 – 1 – 低密度開發項目，擁有豐富的綠化空間設計 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 瑞慈醫療服務控股有限公司（本公司）（於開曼群島注冊成立的有限公司） 呈交日期: 2026年2月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01526 | 說明 | 普通股 | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | USD | | 0.0001 USD | | 1,000,000 | | 增加 / 減少 (-) | | | | | | USD | | | | 本月底結存 | | | 10,000,000,000 | USD | | 0.0001 USD | | 1,000,000 ...

Core Insights - Shanghai Ruici Medical Investment Group and Shanghai Institute of Major Infectious Diseases and Biosecurity signed a strategic cooperation agreement to advance chronic disease health examination standards and collaborate in preventive medicine [1] Group 1: Strategic Cooperation - The agreement aims to establish scientific health examination standards and address potential health management needs [1] - Both parties will leverage their strengths in medical services and technological innovation to enhance public health services and cultivate medical research talent [1] Group 2: Organizational Background - The Shanghai Institute of Major Infectious Diseases and Biosecurity was approved by the Shanghai Municipal Government in July 2020 and officially established in November 2020 [2] - It operates as a public welfare research institution jointly built by the Shanghai Municipal Government and Fudan University, managed under a council-led system [2]

第 1 頁 共 10 頁 v 1.1.1 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 瑞慈醫療服務控股有限公司（本公司）（於開曼群島注冊成立的有限公司） 呈交日期: 2026年1月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01526 | 說明 | 普通股 | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | USD | | 0.0001 USD | | 1,000,000 | | 增加 / 減少 (-) | | | | | | USD | | | | 本月底結存 | | | 10,000,000,000 | USD | | 0. ...

Core Insights - The health service industry aims to create a favorable organizational environment by providing safe, effective, convenient, and affordable basic medical and public health services to meet various health needs of residents. The demand for health-related products and services is rapidly increasing due to social progress and changes in lifestyle [1][7]. Industry Overview - The health service industry encompasses medical services, health management, health insurance, and related services, involving pharmaceuticals, medical devices, health products, and fitness products [4]. - The industry has experienced rapid growth in China, with the market size increasing from 6.37 trillion yuan in 2018 to an expected 9.55 trillion yuan by 2024, representing a compound annual growth rate of 6.98%. The "Healthy China 2030" plan projects the total market size to reach 16 trillion yuan by 2030, indicating significant growth potential [1][8]. Development History - The development of China's health service industry can be divided into four stages: 1. 1949-1990: Health check-ups were primarily hospital services focused on disease detection rather than prevention. 2. 1991-2000: Independent health check-up service institutions began to emerge in cities like Beijing. 3. 2001-2010: The introduction of Western health service concepts and rapid market demand growth led to the fast development of health service institutions. 4. 2011-present: Increased focus on medical information technology and service upgrades has improved the capabilities of health service institutions [4][5]. Relevant Policies - Recent government policies aim to optimize resource allocation, enhance preventive interventions, and improve service accessibility, which helps control the rapid growth of medical costs and reduce the disease burden on families and society. For instance, the National Health Commission issued a notice in February 2025 to address public health concerns and improve service efficiency [6]. Industry Structure and Key Companies - The operational models of health service institutions in China are diverse, including: 1. Hospital-based models leveraging brand and client resources. 2. Independent medical models with self-owned brands and facilities. 3. Health management models centered on health check-ups. 4. Comprehensive information platform models connecting online and offline services [8]. - Major companies in the health service industry include: - Meinian Health Industry Holdings Co., Ltd. - Tongce Medical Co., Ltd. - Ruici Medical Service Holdings Co., Ltd. - Ciming Health Checkup Management Group Co., Ltd. - Aikang Guobin Health Checkup Management Group Co., Ltd. [2][3][9]. Trends in Health Services - The future of health services will focus on personalized and precise care, moving from a "one-size-fits-all" approach to individualized health management based on personal data [11]. - Service delivery will become decentralized, extending beyond traditional healthcare facilities to community and home settings, enhancing accessibility and convenience [12]. - Payment models will evolve from fee-for-service to value-based care, with insurance companies and service providers collaborating to create innovative health products [13].

Core Viewpoint - 瑞慈医疗 announced the resignation of Wang Yong as an independent non-executive director and audit committee member, effective December 29, 2025, to focus on other business matters [1] Group 1 - Wang Yong will dedicate more time to his other business affairs, leading to his resignation [1] - The board has appointed Tian Wenguo as an independent non-executive director to fill the temporary vacancy and as a member of the audit committee, effective December 29, 2025 [1]

Core Viewpoint - Dr. Wang Yong has resigned as an independent non-executive director and member of the audit committee of Ruici Medical (01526) to focus on other business matters, effective December 29, 2025 [1] Group 1 - The company has appointed Mr. Tian Wenguo as an independent non-executive director to fill the temporary vacancy and as a member of the audit committee, effective December 29, 2025 [1] - Mr. Tian will serve until the company's first annual general meeting after his appointment, where he may be re-elected by shareholders [1] - The audit committee will consist of Ms. Huang Siying (Chair), Mr. Jiang Peixing, and Mr. Tian, effective December 29, 2025 [1]

Core Viewpoint - Dr. Wang Yong has resigned as an independent non-executive director and member of the audit committee of Ruici Medical (01526) to focus on other business matters, effective December 29, 2025 [1] Group 1: Board Changes - The board has appointed Mr. Tian Wenguo as an independent non-executive director to fill the temporary vacancy and as a member of the audit committee, effective December 29, 2025 [1] - Mr. Tian will serve until the company's first annual general meeting after his appointment, where he may be re-elected by shareholders [1] Group 2: Audit Committee Composition - Following Dr. Wang's resignation and Mr. Tian's appointment, the audit committee will consist of Ms. Huang Siying (Chair), Mr. Jiang Peixing, and Mr. Tian, effective December 29, 2025 [1]

Core Viewpoint - 瑞慈医疗 announced the resignation of independent non-executive director Wang Yong to focus on other business matters, effective December 29, 2025 [1] Group 1 - Wang Yong's resignation includes his position on the company's audit committee [1] - The board has appointed Tian Wenguo as the independent non-executive director to fill the temporary vacancy, also effective December 29, 2025 [1]

RICI HEALTHCARE HOLDINGS LIMITED （於開曼群島註冊成立的有限公司） （股份代號：1526） 董事名單與其角色和職能 瑞慈醫療服務控股有限公司董事會（「董事會」）成員載列如下： 執行董事 獨立非執行董事 黃斯穎女士 姜培興先生 田文果先生 董事會設有三個董事委員會。董事委員會的組成如下： 審核委員會 黃斯穎女士 （主席） 姜培興先生 田文果先生 方宜新醫師 （主席兼行政總裁） 梅紅醫師 方浩澤先生 林曉穎女士 方宜新醫師 （主席） 黃斯穎女士 姜培興先生 中國上海，2025年12月29日 薪酬委員會 姜培興先生 （主席） 黃斯穎女士 梅紅醫師 提名委員會 ...